title: Did media attention of the 2009 A(H1N1) influenza epidemic increase outpatient antibiotic use in France?: A time-series analysis.
abstract: BACKGROUND
  In France, the 2009 A(H1N1) influenza epidemic occurred between September 2009 and January 2010. Sparking widespread controversy, it was intensely reported in the media. Despite therapeutic inefficacy, antibiotic consumption and viral respiratory infections are positively correlated, particularly in France, where antibiotic overconsumption is well-known. We first determined the period when media coverage was high, and then compared, during this period, observed outpatient antibiotic consumption to estimated outpatient antibiotic consumption "without media attention".
  
  
  METHODS
  TO EVALUATE MEDIA COVERAGE, TWO ONLINE DATABASES WERE CONSULTED: Factiva and Europresse. To quantify outpatient antibiotic consumption, we used data on reimbursements of outpatient systemic antibiotics from the computerized databases of the two main National Health Insurance agencies. Influenza-like syndromes data came from the French GPs Sentinelles Network. Weekly time-series of antibiotic consumption were modeled by autoregressive moving-average models with exogenous inputs and interventions. Analyses were computed for the entire series and by age group (0-5, 6-15, 16-60, and >60 years).
  
  
  RESULTS
  Media coverage was intense between April 2009 and January 2010. No effect on total outpatient antibiotic consumption was observed during the whole mediatic period. However, during the epidemic in France (September 2009-January 2010), we found an antibiotic underconsumption for the entire series, 0-5 and >60 years. Additionally, at the beginning of the pandemic, when cases were still outside France (June 2009-August 2009), we found an antibiotic overconsumption for patients >16 years.
  
  
  CONCLUSIONS
  The early period of A(H1N1) virus circulation compared with seasonal influenza or an overdeclaration of ILS cases might explain the antibiotic underconsumption observed during the period of active A(H1N1) virus transmission in France. At the pandemic onset, when uncertainty was high, the overconsumption observed for individuals >16 years might have been caused by alarmist media reporting. Additional analyses are needed to understand the determinants of antibiotic consumption during this period.
authors.affiliation: INSERM, U 657, Paris, France.
authors.forename: Adeline
authors.initials: A
authors.lastname: Bernier
authors.forename: Caroline
authors.initials: C
authors.lastname: Ligier
authors.forename: Didier
authors.initials: D
authors.lastname: Guillemot
authors.forename: Laurence
authors.initials: L
authors.lastname: Watier
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005602:France; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000472:pathogenicity*; D007251:Influenza, Human / Q000453:epidemiology* / Q000821:virology; D008402:Mass Media / Q000706:statistics & numerical data*; D010045:Outpatients / Q000706:statistics & numerical data*
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Int J Antimicrob Agents. 2010 Nov;36 Suppl 3:S3-7
references.pmid: 21129629
references.citation: Int J Med Microbiol. 2010 Aug;300(6):351-6
references.pmid: 20434950
references.citation: Lancet. 2005 Feb 12-18;365(9459):579-87
references.pmid: 15708101
references.citation: Stat Methods Med Res. 1996 Mar;5(1):3-22
references.pmid: 8743076
references.citation: Emerg Infect Dis. 2008 Nov;14(11):1722-30
references.pmid: 18976555
references.citation: Am J Public Health. 1986 Nov;76(11):1289-92
references.pmid: 3766824
references.citation: Clin Microbiol Infect. 2008 Apr;14(4):298-306
references.pmid: 18093237
references.citation: Clin Microbiol Infect. 2010 Apr;16(4):326-9
references.pmid: 20121829
references.citation: Clin Infect Dis. 2011 May;52 Suppl 4:S284-9
references.pmid: 21460286
references.citation: PLoS Med. 2009 Jun 2;6(6):e1000084
references.pmid: 19492093
references.citation: MMWR Morb Mortal Wkly Rep. 2006 Mar 17;55(10):277-9
references.pmid: 16543882
references.citation: Eur J Clin Pharmacol. 2006 Dec;62(12):1055-64
references.pmid: 17021889
references.citation: Euro Surveill. 2011 Jan 20;16(3):
references.pmid: 21262184
references.citation: Clin Microbiol Infect. 2010 Apr;16(4):322-5
references.pmid: 20121828